Fulvia Ceccarelli: Efficacy of Anifrolumab in Lupus-Associated Autoimmune Haemolytic Anaemia
Fulvia Ceccarelli, Associate Professor of Rheumatology at Sapienza University of Rome, shared a post on LinkedIn about a recent article she and her colleagues co-authores, published in Lupus Science and Medicine, adding:
“We are proud to share our last contribution on efficacy of anifrolumab on lupus autoimmune haemolytic anaemia.
The study is the result of a spontaneous and friendly collaboration among centers in various Italian region.”
Title: Targeting type I interferon in lupus autoimmune haemolytic anaemia: first report with anifrolumab
Authors: Fulvia Ceccarelli, Rossella De Angelis, Francesca Bottazzi, Danila Madonna, Melania Alessia Coscia, Noemi Italiano, Emanuela Praino, Emanuela Sabatini, Leonardo Santo, Lorenzo Cavagna, Fabrizio Conti
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios AndreadisÖ‰ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI